[EspdRequest]

Validation errors

[CreatecaHeader]

[CreatecaInfoPub]

[CreatecaToBeFilledAlert]

[CreatecaOjsLabel]

[CreatecaOfficialJournalAlert]

[CreatecaContactDetailsCa]

[CreatecaName] Statens Serum Institute

[CreatecaCountry] Denmark

[CreatecaInfoProcurementProc]

[CreatecaProcurerName] Purchase and installation of a VHP pass through decontamination chamber

[CreatecaFileRefCa]

[CreatecaTitleOrShortDesc] This procurement procedure concerns the award of a Contract regarding the purchase and installation of a VHP pass through decontamination chamber at Statens Serum Institute, Denmark (hereafter noted as SSI). The description of the tendered Solution is found in Appendices 2, 2.1 – 2.6. SSI conducts research in infectious diseases by in vivo testing primarily in rodents, requiring containment measures for biosafety level (BSL) 3 and “Genetically Modified Organism” GMO class 1-2. In accordance with local and international guidelines on biosafety containment, materials and equipment for reuse, and contaminated waste, must be decontaminated before removal from the building.

[CreatecaexclHeader]

[CritTopTitleGroundsCriminalConv]

[CritEuMainTitleGroundsCriminalConv]

[Crit_005eb9ed-1347-4ca3-bb29-9bc0db64e1ab_Name]

[Crit_005eb9ed-1347-4ca3-bb29-9bc0db64e1ab_Descript]

[Crit_c27b7c4e-c837-4529-b867-ed55ce639db5_Name]

[Crit_c27b7c4e-c837-4529-b867-ed55ce639db5_Descript]

[Crit_297d2323-3ede-424e-94bc-a91561e6f320_Name]

[Crit_297d2323-3ede-424e-94bc-a91561e6f320_Descript]

[Crit_d486fb70-86b3-4e75-97f2-0d71b5697c7d_Name]

[Crit_d486fb70-86b3-4e75-97f2-0d71b5697c7d_Descript]

[Crit_47112079-6fec-47a3-988f-e561668c3aef_Name]

[Crit_47112079-6fec-47a3-988f-e561668c3aef_Descript]

[Crit_d789d01a-fe03-4ccd-9898-73f9cfa080d1_Name]

[Crit_d789d01a-fe03-4ccd-9898-73f9cfa080d1_Descript]

[CritTopTitleGroundsPaymentTaxes]

[CritEuMainTitlePaymentTaxes]

[Crit_b61bbeb7-690e-4a40-bc68-d6d4ecfaa3d4_Name]

[Crit_b61bbeb7-690e-4a40-bc68-d6d4ecfaa3d4_Descript]

[Crit_7d85e333-bbab-49c0-be8d-c36d71a72f5e_Name]

[Crit_7d85e333-bbab-49c0-be8d-c36d71a72f5e_Descript]

[CritTopTitleInsolvencyConflicts]

[CritEuMainBreachingObligations]

[Crit_514d3fde-1e3e-4dcd-b02a-9f984d5bbda3_Name]

[Crit_514d3fde-1e3e-4dcd-b02a-9f984d5bbda3_Descript]

[Crit_b1b5ac18-f393-4280-9659-1367943c1a2e_Name]

[Crit_b1b5ac18-f393-4280-9659-1367943c1a2e_Descript]

[Crit_61874050-5130-4f1c-a174-720939c7b483_Name]

[Crit_61874050-5130-4f1c-a174-720939c7b483_Descript]

[Crit_696a75b2-6107-428f-8b74-82affb67e184_Name]

[Crit_696a75b2-6107-428f-8b74-82affb67e184_Descript]

[CreatecaselHeader]

[CreatecaselEconomicAndFinancialStanding]

[CritSelectionEoEconomicArticle]

[Crit_499efc97-2ac1-4af2-9e84-323c2ca67747_Name]

[Crit_499efc97-2ac1-4af2-9e84-323c2ca67747_Descript]

[CreatecaselTechnicalProfessionalAbility]

[CritSelectionTechnicalProfessionalAbilityArticle]

[Crit_3a18a175-1863-4b1d-baef-588ce61960ca_Name]

[Crit_3a18a175-1863-4b1d-baef-588ce61960ca_Descript]